Loading...
Price History
Market Data
| Market Cap | 86.70B |
| P/E Ratio | - |
| P/B Ratio | 1.98 |
| EPS | - |
| Dividend Yield | 1.51% |
| D/E Ratio | 1.77 |
| Current Ratio | 1.54 |
| Currency | USD |
Key Financial Metrics
199.12B
Revenue
5.66B
Net Income
-
EPS (Diluted)
6.60B
Free Cash Flow
Profitability
Gross Margin
89.4%
Operating Margin
-
Net Profit Margin
2.8%
EBITDA
-
Returns & Efficiency
Return on Assets (ROA)
4.7%
Return on Equity (ROE)
12.9%
Dividend Yield
1.51%
EPS
-
Financial Health
Total Assets
121.49B
Total Debt
32.05B
Debt to Equity
1.77x
Current Ratio
1.54
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| HQ | INDIANAPOLIS, IN |
| Fiscal Year | 2025 |
Peers
322.71B
P/E: --
CIGNA CORP
CI
74.58B
P/E: --
CIGNA GROUP
CI
74.58B
P/E: --
HUMANA INC
HUM
32.05B
P/E: --
CENTENE CORP
CNC
22.65B
P/E: --
10.94B
P/E: --
10.94B
P/E: --
4.76B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$86.70B
P/E Ratio (TTM)-
Price to Book1.98
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin89.4%
Operating Margin-
Net Margin2.8%
ROE12.9%
ROA4.7%
Leverage & Liquidity
Debt to Equity1.77
Current Ratio1.54
Total Debt$32.05B
Total Assets$121.49B
Stockholders' Equity$43.88B
Income Statement (FY 2025)
Revenue$199.12B
Gross Profit$177.95B
Operating Income-
Net Income$5.66B
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$6.60B
Cash & Equivalents$9.49B
Revenue Growth12.5%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 220 VIRGINIA AVENUE INDIANAPOLIS, IN 46204 |
| Phone | 8003311476 |
| Incorporated | IN, US |
| EIN | 352145715 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 220.70M |
| Stockholders' Equity | $43.88B |
| Cash & Equivalents | $9.49B |
Recent Filings
View All
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-22
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-04-22
Local
PX14A6G
PX14A6G Filing
SEC regulatory filing
Filed: 2026-04-07
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-26
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-09
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | ELEVANCE HEALTH, INC. |
| Ticker | ELV |
| Exchange | -- |
| Sector | Finance & Insurance |
| Industry | -- |
| Headquarters | INDIANAPOLIS, IN |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 86.70B |
| Revenue | 199.12B |
| Net Income | 5.66B |
| P/E Ratio | - |
| EPS | - |
| Net Margin | 2.8% |
| ROE | 12.9% |
| Dividend Yield | 1.51% |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...